Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations.

Song P, Li K, Liu L, Wang X, Jian Z, Zhang W, Wang G, Li C, Gao T.

J Cell Mol Med. 2016 Oct;20(10):1840-50. doi: 10.1111/jcmm.12874.

2.

Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism.

Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J.

Cell Mol Life Sci. 2016 Sep;73(17):3221-47. doi: 10.1007/s00018-016-2223-0. Review.

3.

Small Maf proteins (MafF, MafG, MafK): History, structure and function.

Katsuoka F, Yamamoto M.

Gene. 2016 Jul 25;586(2):197-205. doi: 10.1016/j.gene.2016.03.058. Review.

PMID:
27058431
4.

Nrf2 and Nrf2-related proteins in development and developmental toxicity: Insights from studies in zebrafish (Danio rerio).

Hahn ME, Timme-Laragy AR, Karchner SI, Stegeman JJ.

Free Radic Biol Med. 2015 Nov;88(Pt B):275-89. doi: 10.1016/j.freeradbiomed.2015.06.022. Review.

6.

Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver.

Masuda Y, Vaziri ND, Takasu C, Li S, Robles L, Pham C, Le A, Vo K, Farzaneh SH, Stamos MJ, Ichii H.

Gastroenterol Hepatol (Que). 2014;1(1):1-7.

7.

Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes.

Luo X, Xiao L, Yang H, Zhang R, Jiang M, Ni J, Lei T, Wang N.

Nutr Metab (Lond). 2014 Dec 8;11(1):55. doi: 10.1186/1743-7075-11-55.

8.

Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Crispino JD, Weiss MJ.

Blood. 2014 May 15;123(20):3080-8. doi: 10.1182/blood-2014-01-453167. Review.

9.

p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition.

Radhakrishnan SK, den Besten W, Deshaies RJ.

Elife. 2014;3:e01856. doi: 10.7554/eLife.01856.

10.

Developmental expression of the Nfe2-related factor (Nrf) transcription factor family in the zebrafish, Danio rerio.

Williams LM, Timme-Laragy AR, Goldstone JV, McArthur AG, Stegeman JJ, Smolowitz RM, Hahn ME.

PLoS One. 2013 Oct 24;8(10):e79574. doi: 10.1371/journal.pone.0079574.

11.

Nuclear factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) modulates dendritic cell immune function through regulation of p38 MAPK-cAMP-responsive element binding protein/activating transcription factor 1 signaling.

Al-Huseini LM, Aw Yeang HX, Sethu S, Alhumeed N, Hamdam JM, Tingle Y, Djouhri L, Kitteringham N, Park BK, Goldring CE, Sathish JG.

J Biol Chem. 2013 Aug 2;288(31):22281-8. doi: 10.1074/jbc.M113.483420.

13.

Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia.

Aumann K, Frey AV, May AM, Hauschke D, Kreutz C, Marx JP, Timmer J, Werner M, Pahl HL.

Blood. 2013 Jul 4;122(1):93-9. doi: 10.1182/blood-2012-11-463257.

14.

Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1.

Biswas M, Kwong EK, Park E, Nagra P, Chan JY.

Exp Cell Res. 2013 Aug 1;319(13):1922-31. doi: 10.1016/j.yexcr.2013.04.013.

15.

OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.

Matsubara Y, Ono Y, Suzuki H, Arai F, Suda T, Murata M, Ikeda Y.

PLoS One. 2013;8(3):e58123. doi: 10.1371/journal.pone.0058123.

16.

Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasms.

Wehrle J, Seeger TS, Schwemmers S, Pfeifer D, Bulashevska A, Pahl HL.

Haematologica. 2013 Jul;98(7):1073-80. doi: 10.3324/haematol.2012.071183.

17.

Transcription factors in late megakaryopoiesis and related platelet disorders.

Tijssen MR, Ghevaert C.

J Thromb Haemost. 2013 Apr;11(4):593-604. doi: 10.1111/jth.12131. Review.

18.
19.

Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis.

Xu J, Shao Z, Glass K, Bauer DE, Pinello L, Van Handel B, Hou S, Stamatoyannopoulos JA, Mikkola HK, Yuan GC, Orkin SH.

Dev Cell. 2012 Oct 16;23(4):796-811. doi: 10.1016/j.devcel.2012.09.003.

20.

Phosphorylation-dependent SUMOylation of the transcription factor NF-E2.

Su YF, Shyu YC, Shen CK, Hwang J.

PLoS One. 2012;7(9):e44608. doi: 10.1371/journal.pone.0044608.

Items per page

Supplemental Content

Support Center